|Bid||84.55 x 3500|
|Ask||84.65 x 4300|
|Day's Range||84.34 - 84.88|
|52 Week Range||66.93 - 86.90|
|PE Ratio (TTM)||31.90|
|Dividend & Yield||2.72 (3.23%)|
|1y Target Est||N/A|
Novartis AG (ADR) (NYSE: NVS ) has been all over the news lately as its cancer drug moves closer to FDA approval, and Morgan Stanley analyst Vincent Meunier believes the recent news flow suggests a less ...
Glaxo's (GSK) Q2 earnings beat estimate, with revenue missing the same. Glaxo lowered its core 2017 earnings growth in the quarter, with no Advair generics are launched this year.
For 2Q17, Alcon reported a 1.0% growth in revenues to $1.52 billion compared to $1.51 billion in 2Q16.